Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „eltrombopag“
Suchtreffer
Begriffe & Kennungen
Revolade · 4.5 · Effects of eltrombopag on other medicinal products
Eintrag öffnenRevolade · 4.5 · Effects of other medicinal products on eltrombopag
Eintrag öffnenRevolade · 4.5 · Eltrombopag chelates with polyvalent cations such as iron, calcium, magnesium, aluminium, selenium and zinc. A
Eintrag öffnenRevolade · 4.5 · Eltrombopag chelates with polyvalent cations such as iron, calcium, magnesium, aluminium, selenium and zinc. A
Eintrag öffnenRevolade · 4.5 · Eltrombopag is metabolised through multiple pathways including CYP1A2, CYP2C8, UGT1A1, and UGT1A3 (see section
Eintrag öffnenRevolade · 4.5 · Eltrombopag is metabolised through multiple pathways including CYP1A2, CYP2C8, UGT1A1, and UGT1A3 (see section
Eintrag öffnenRevolade · 4.5 · In studies utilising human liver microsomes, eltrombopag (up to 100 M) showed no in vitro inhibition of the C
Eintrag öffnenRevolade · 4.5 · In studies utilising human liver microsomes, eltrombopag (up to 100 M) showed no in vitro inhibition of the C
Eintrag öffnenRevolade · 4.5 · Medicinal products used in the treatment of ITP in combination with eltrombopag in clinical studies included c
Eintrag öffnenRevolade · 4.5 · Medicinal products used in the treatment of ITP in combination with eltrombopag in clinical studies included c
Eintrag öffnenRevolade · 4.5 · The administration of eltrombopag tablet or powder for oral suspension formulations with a high- calcium meal
Eintrag öffnenRevolade · 4.5 · The administration of eltrombopag tablet or powder for oral suspension formulations with a high- calcium meal
Eintrag öffnenRevolade · 4.8 · 21 In the phase II refractory SAA clinical study with eltrombopag at a dose of 150 mg/day (with ethnic or age
Eintrag öffnenRevolade · 4.8 · ENABLE 1 (TPL103922 n=716, 715 treated with eltrombopag) and ENABLE 2 (TPL108390 n=805) were randomised, doubl
Eintrag öffnenRevolade · 4.8 · ENABLE 1 (TPL103922 n=716, 715 treated with eltrombopag) and ENABLE 2 (TPL108390 n=805) were randomised, doubl
Eintrag öffnenRevolade · 4.8 · In 3 controlled and 2 uncontrolled clinical studies among adult ITP patients receiving eltrombopag (n=446), 17
Eintrag öffnenRevolade · 4.8 · In 3 controlled and 2 uncontrolled clinical studies among adult ITP patients receiving eltrombopag (n=446), 17
Eintrag öffnenRevolade · 4.8 · In the controlled clinical studies in chronic ITP with eltrombopag, increases in serum ALT, AST and bilirubin
Eintrag öffnenRevolade · 4.8 · In the controlled clinical studies in chronic ITP with eltrombopag, increases in serum ALT, AST and bilirubin
Eintrag öffnenRevolade · 4.8 · In the phase II refractory SAA clinical study with eltrombopag at a dose of 150 mg/day (with ethnic or age rel
Eintrag öffnen